...
Conclusion
The preliminary results announced for AB-SA01 in the Phase 1 study in patients with CRS are very encouraging, particularly since AB-SA01 was able to safely eradicate S. aureus in two patients that were refractory to antibiotic treatment. We look forward to the full results from the study later in 2016, which we believe is likely to show similar results in Cohort 3 that were seen in Cohort 2.
We have constructed a probability adjusted discounted cash flow model that takes into account the potential market for treating CRS patients with AB-SA01, cystic fibrosis patients with AB-PA01, as well as the amount of capital that will be required to get the first product to market. Our current valuation for AmpliPhi is $11/share, and we continue to remain positive on the AmpliPhi story and believe that bacteriophage therapy has tremendous potential as a treatment for serious and life-threatening bacterial infections.
Recent ARMP News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 11:50:05 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:20:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:09:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:25:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:50 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:35:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:03:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2024 09:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:27 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2023 10:24:56 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM